Christopher Robinson/LinkedIn
Nov 10, 2025, 12:38
Christopher Robinson: Early Low sFlt-1 May Predict Preeclampsia
Christopher Robinson, Physician/Partner at Charleston Maternal Fetal Medicine, shared a post on LinkedIn about a paper by Emmanuel Bujold et al. published in AJOG:
“A low maternal soluble fms-like tyrosine kinase-1 before 11 weeks is associated with a greater risk of early preeclampsia.”
Title: A low maternal soluble fms-like tyrosine kinase-1 before 11 weeks is associated with a greater risk of early preeclampsia
Authors: Emmanuel Bujold, Charlotte K. Ekelund, Berit Woetmann Pedersen, Line Rode
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Mar 21, 2026, 19:55Rebecca Mallick: Fertility Must Become Standard in Endometriosis Care
-
Mar 21, 2026, 19:48Kendra Batchelder: The Momentum Behind Women’s Health Innovation
-
Mar 21, 2026, 19:44COVID-19 Vaccination During Pregnancy in 2026 – Weence Health Content Services
-
Mar 21, 2026, 19:37Endometriosis and the Endocannabinoid System – ANTG
-
Mar 21, 2026, 19:35Corina Carpenter: A Guide to Clinical Trial Compensation in San Antonio
-
Mar 21, 2026, 19:31The Signals Behind PCOS – PCOS Awareness Association
-
Mar 21, 2026, 19:26Paternal Impact on Embryo Morphokinetics and ART Success – RBMO
-
Mar 21, 2026, 19:19Christopher Robinson: Maternal Fetal Pharmacokinetics of Azithromycin in Preterm Premature Rupture of Membranes
-
Mar 21, 2026, 19:13Lori Brumat: Why Women’s Health Should Matter to Everyone Right Now